Study answers Medicare concerns about paying for CT colonography

July 1, 2012

A new study of 1,400 Medicare-aged patients reinforces CT colonography as a screening tool for colon cancer, adding to the continued debate over Medicare coverage of the procedure.

In 2009, the Centers for Medicare and Medicaid Services indicated that CT colonography would not be covered, in part, because outcomes data specific to the Medicare population was not available.

"Our study answers several of the questions Medicare asked about this procedure," said Brooks Cash, MD, one of the authors of the study. The study found that the percentage of patients that would have been referred to as a result of CT colonography was 14%, which is similar to what other studies have found in the younger population, said Dr. Cash. "The prevalence of neoplasia (abnormal growths of cells) detected by CT colonography was 9.3% in patients over the age of 65," which is also similar to the results of other studies involving younger patients," he said.

Potentially important extracolonic findings were identified in 2.9% of the study group. "The confirmation of low rates of referral to colonoscopy, the prevalence of advanced neoplasia and the prevalence of extracolonic findings makes CT colonography a viable option for Medicare-aged patients," said Dr. Cash.

The Centers for Medicare and Medicaid Services had also expressed concern about the of colonoscopy, said Dr. Cash. "The average effective radiation dose with CT colonography at the National Naval Medical Center in Bethesda, MD (where the study was conducted) was calculated to be 4.24 mSv per CT colonography examination. To put that in perspective, the average yearly of American adults is about 6.2mSv," Dr. Cash said.

Several previous studies have shown that up to 40% of individuals undergoing CT colonography say they would not have been screened for if CT colonography had not been available to them. "This is the real value of CT colonography – offering an alternative, high quality, total colonic preventative screening to a large percentage of the population that either refuses or is unable to undergo colonoscopy," said Dr. Cash.

Currently about 50-60% of patients eligible for colon cancer screening undergo any kind of screening examination; "we have calculated in our practice that we could increase screening compliance rates by about 15% if was covered by Medicare or third party payers," Dr. Cash said.

The study appears in the July, 2012 American Journal of Roentgenology, published by the American Roentgen Ray Society.

Explore further: CT colonography shown to be comparable to standard colonoscopy

Related Stories

CT colonography shown to be comparable to standard colonoscopy

February 23, 2012
Computerized tomographic (CT) colonography (CTC), also known as virtual colonoscopy, is comparable to standard colonoscopy in its ability to accurately detect cancer and precancerous polyps in people ages 65 and older, according ...

Colon Cancer Alliance and American College of Radiology demand Medicare cover virtual colonoscopy

February 23, 2012
In response to a study published online Feb. 23 in Radiology which showed that virtual colonoscopies are comparably affective to standard colonoscopy at detecting colorectal cancer and precancerous polyps in adults ages 65 ...

Study: Virtual colonoscopy effective screening tool for adults over 65

February 23, 2012
Computed tomography (CT) colonography can be used as a primary screening tool for colorectal cancer in adults over the age of 65, according to a new study published online in the journal Radiology.

Recommended for you

Researchers discover a new target for 'triple-negative' breast cancer

November 20, 2017
So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

Study reveals new mechanism used by cancer cells to disarm attacking immune cells

November 20, 2017
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James) identifies a substance released by pancreatic cancer cells that protects ...

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.